LONG-TERM BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH HDV-RELATED COMPENSATED CIRRHOSIS: EFFECTIVENESS, SAFETY AND CLINICAL OUTCOMES FROM THE RETROSPECTIVE MULTICENTER EUROPEAN STUDY (SAVE-D)

Conference Reports for NATAP

The Liver Meeting
AASLD 2024
Nov 15-19,
San Diego, CA